news & events




March 2018

AROMICS to participate at the annual meeting of the International Mesothelioma Group iMig in Ottawa, Canada

AROMICS will be present on the 14th meeting of the International Mesothelioma Interest Group (iMig 2018) to be held in Ottawa, Canada in May 2018. During the congress the company will present new data with the compound NAX035, on the mechanism of action and preclinical efficacy in experimental models of mesothelioma. The work presented...


January 2018

METACAN project launches its web

AROMICS is one of the participants of the METACAN european  research project. This training network provides a pan-European interdisciplinary and intersectoral training programme of excellence bringing young researchers together with world-leading academics,...


December 2017

AROMICS partipates at the SME Capital Forum

Closing the year with the company presentacion at the 32 editiion of SME Capital Forum organized at Bolsa de Madrid.


September 2017

Dr. Lombardi will present recent advances on berberine antitumor agents at the 15th IDDST 2017 meeting

Dr. Paolo Lombardi, CEO of Naxospharma, a close collaborator of AROMICS, will give a talk on in session 801: New anticancer agents.  The talk will reveal the  Recent Advances in the anti-tumour Berberine. The session will take place on 10th November, at 14.40 pm during the 15th Annual...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9